NYSE:ELPC 28 December 2025

Companhia Paranaense de Energia (Copel) Stock Update: ELPC Debuts After Mandatory ADR Conversion—What Investors Need to Know Before Monday

Copel’s preferred American Depositary Shares (NYSE: ELP) were mandatorily converted into common ADS under the new ticker NYSE: ELPC, following a governance overhaul. ELPC closed Friday at $9.65, up 8.92% on light volume after the conversion. Each ELP ADS converts to one ELPC ADS, with a $0.57315 cash dividend per ELP ADS payable Jan. 9. ELP is now delisted in the U.S.

28 December 2025

Energy Sector·NYSE:ELPC·Stock Market

Telix Pharmaceuticals Shares Surge 12.9% After TLX101-Px FDA NDA Resubmission and U.S. Manufacturing Expansion
March 20, 2026, 1:35 PM EDT. Telix Pharmaceuticals (ASX:TLX) jumped 12.9% following its March 2026 resubmission of the New Drug Application (NDA) for TLX101-Px (Pixclara) to the U.S. FDA. The investigational PET imaging agent targets brain cancer diagnosis, specifically glioma, with no current FDA-approved equivalents in the U.S. The resubmission includes new data after a prior Complete Response Letter and benefits from Orphan Drug and Fast Track designations. Concurrently, Telix's U.S. manufacturing build-out, including cyclotron orders for isotope production, aims to scale supply for future launches. While analysts project revenue of A$1.2 billion and earnings of A$111 million by 2029, the company faces risks from heavy R&D and manufacturing investments that may pressure margins if commercialization stalls. Investors are weighing potential near-term catalysts against execution and development uncertainties.